Cabilly preliminary motions
18. Cabilly filed the following nine preliminary motions:
a. Cabilly preliminary motion 1 under 37 CFR § 1.633(a) for judgment that
the claims of the '403, '404, and '405 Glaxo patent are unpatentable under 35 USC § 102 or
§ 103 in view of "the Shively work" (Paper 65).
b. Cabilly preliminary motion 2 under 37 CFR § 1.633(a) for judgment that
the claims of the '405 patent are unpatentable under 35 USC § 102 or § 103 in view of prior art
cited by Glaxo (Paper 66).
c. Cabilly preliminary motion 3 under 37 CFR § 1.633(a) for judgment that
the claims of the '403, '404, and '405 Glaxo patents are unpatentable under 35 USC § 102 or
§ 103 in view of "the Capon work" (Paper 67).
d. Cabilly preliminary motion 4 under 37 CFR § 1.633(a) for judgment that
the claims of the '403, '404, and '405 Glaxo patents are unpatentable under 35 USC § 112, ¶1, for
failure to provide an enabling disclosure (Paper 68).
e. Cabilly preliminary motion 5 under 37 CFR § 1.633(a) for judgment that
the claims of the '403, '404, and '405 Glaxo patents are unpatentable under 35 USC § 102(f) on
the basis that Martin J. Page is not the inventor of the claimed subject mater (Paper 69).
f. Cabilly preliminary motion 6 under 37 CFR § 1.633(a) for judgment that
the claims of the claims of the '403, '404, and '405 Glaxo patents are unpatentable under 35 USC
§ 102(a), 35 USC § 102(b), or 35 USC § 103, in view of clinical trials conducted in 1989-1991
(Paper 70).
-9-
Page: Previous 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Next
Last modified: November 3, 2007